praziquantel
anthelmintic· Brands: Biltricide, Cysticide, Distocide, DroncitPO
Schistosomiasis due to Schistosoma mansoni or S. haematobium
Take with food if possible to reduce nausea. May repeat after 4-6 weeks if response incomplete.
- adult · PO: 40 mg/kg single dose · Take with food if possible to reduce nausea. May repeat after 4-6 weeks if response incomplete.
Schistosomiasis due to S. japonicum or S. mekongi
Single oral dose. Repeat if necessary.
- adult · PO: 60 mg/kg single dose · Single oral dose. Repeat if necessary.
Neurocysticercosis (adjunctive therapy)off-label
Used with corticosteroids and anticonvulsants. Monitor for raised intracranial pressure.
- adult · PO: 50 mg/kg/day TID for 15 days · Used with corticosteroids and anticonvulsants. Monitor for raised intracranial pressure.
Taeniasis (Taenia saginata or T. solium infection)
Single dose. May be repeated after 2 weeks if needed.
- adult · PO: 10 mg/kg single dose · Single dose. May be repeated after 2 weeks if needed.
Hymenolepiasis (Hymenolepis nana infection)off-label
Single dose, repeat after 2 weeks up to 2 times. Approval varies by region.
- adult · PO: 25 mg/kg single dose · Single dose, repeat after 2 weeks up to 2 times. Approval varies by region.
- Ocular cysticercosis · Risk of irreversible retinal damage from inflammatory reaction to dying cysts.
- Hypersensitivity to praziquantel · Anaphylactic reactions have been reported.
- Take praziquantel with a meal (especially a fatty meal) to enhance absorption.
- Caution in hepatic impairment: reduce dose or monitor closely, as metabolism is reduced.
- In neurocysticercosis, consider corticosteroid cover to reduce inflammatory reaction around dying cysts.
- Avoid concurrent use with rifampicin, as it significantly lowers praziquantel plasma concentrations.
- Abdominal pain
- Headache
- Dizziness
- Nausea and vomiting
- Seizuresserious
- Hypersensitivity reactions (e.g. urticaria, anaphylaxis)serious
- Hepatic impairment (mild): No dose adjustment required.
- Hepatic impairment (moderate): No dose adjustment required, but monitor for adverse effects.
- Hepatic impairment (severe): Use with caution; consider reducing the dose and monitor liver function.
- Stool or urine examination for ova · Before treatment and 4 weeks after
- Resolution of symptoms · During and after treatment
- Liver function tests (ALT, AST) · In patients with hepatic impairment, before and during treatment
- Adverse effects (nausea, headache, dizziness, abdominal pain) · During treatment
- Pregnancy: Use only if clearly necessary, especially in the first trimester. For schistosomiasis, consider deferring treatment until after delivery if the condition is not urgent; if treatment is required, it may be given after the first trimester.
- Toxicity: Gastrointestinal effects (nausea, vomiting, abdominal pain) · Supportive care; consider antiemetics.
- Toxicity: Central nervous system effects (headache, dizziness, drowsiness, seizures) · Supportive care; treat seizures with benzodiazepines (e.g., diazepam).
- Toxicity: Hypotension · IV fluids and vasopressors if needed.
Log in to read the full praziquantel monograph
A free account unlocks the complete drug reference, the interaction checker, prescription practice and every other learning tool.
BNF; local formulary